SCHEMBL7685728

SCHEMBL7685728

C=CCN1C2CCCC1CC(C#N)(c1cncc(Cl)c1)C2

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.34
OPRL1 P41146 1/20 0.32
SLC6A4 P31645 2/20 0.30
SLC6A3 Q01959 2/20 0.30
CTSS P25774 1/20 0.30
CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7229023 0.95 OPRL1 (0.35) OPRL1
SCHEMBL6617204 0.86 TRPA1 (0.34) OPRL1SLC6A4SLC6A3CTSSCTSK
SCHEMBL6621538 0.83 OPRL1 (0.33) LMNAOPRL1SLC6A4SLC6A3
SCHEMBL7685312 0.82 OPRL1 (0.39) LMNAOPRL1CTSSCTSK
SCHEMBL7220976 0.82 OPRL1 (0.33) OPRL1
SCHEMBL6613896 0.82 OPRL1 (0.37) OPRL1SLC6A4SLC6A3CTSSCTSK
SCHEMBL16565846 0.81 OPRL1 (0.35) OPRL1
SCHEMBL16555300 0.81 OPRL1 (0.35) OPRL1
SCHEMBL379213 0.81 OPRL1 (0.35) OPRL1
SCHEMBL7229259 0.81 OPRL1 (0.36) OPRL1SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020061913-A1 Bicyclic amine derivatives SYNGENTA LIMITED (GB) 2002-05-23 US disclosed
US-6291474-B1 COMBATING AND CONTROLLING INSECT, ACARINE OR NEMATODE PESTS ZENECA LIMITED (GB) 2001-09-18 US disclosed
US-6177442-B1 INSECTICIDES; PESTICIDES; MITICIDES; NEMATOCIDES ZENECA LIMITED (GB) 2001-01-23 US disclosed
US-5968947-A INSECTICIDES, ACARICIDES, NEMATOCIDES ZENECA LIMITED (GB) 1999-10-19 US disclosed
EP-0944627-A1 8-AZABICYCLO 3.2.1]OCTANE-, 8-AZABICYCLO 3.2.1]OCT-6-ENE-, 9-AZABICYCLO 3.3.1]NONANE-, 9-AZA-3-OXABICYCLO 3.3.1]NONANE- AND 9-AZA-3-THIABICYCLO 3.3.1]NONANE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INSECTICIDES ZENECA LIMITED (GB) 1999-09-29 EP disclosed
WO-1998025924-A1 8-AZABICYCLO[3.2.1]OCTANE-, 8-AZABICYCLO[3.2.1]OCT-6-ENE-, 9-AZABICYCLO[3.3.1]NONANE-, 9-AZA-3-OXABICYCLO[3.3.1]NONANE- AND 9-AZA-3-THIABICYCLO[3.3.1]NONANE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INSECTICIDES ZENECA LIMITED (GB) 1998-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061913-A1 Bicyclic amine derivatives ADRA1D, TAAR1, ADRA1A LMNA 2203/4885OPRL1 497/4885SLC6A4 3289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.